← Back to headlines
AbCellera Biologics Prices Oversubscribed $200M Offering
AbCellera Biologics has priced its oversubscribed $200 million offering at $9.75 per share, indicating strong investor interest.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
